Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer|April 1, 2021
Racial differences in no-show rates for screening mammographyWhitney L Hensing, Steven P Poplack, Cheryl R Herman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2021
Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast OncologistsFoluso O Ademuyiwa, Patricia Salyer, Yu Tao, et al.Breast Cancer Research : BCR|October 2, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal WomenCarol J Fabian, Bruce F Kimler, Teresa A Phillips, et al.Breast Cancer Research and Treatment|May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomesArielle J Medford, Marko Velimirovic, Yifat Gefen, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2015
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal WomenCarol J Fabian, Bruce F Kimler, Teresa A Phillips, et al.JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast CancerWhitney L Hensing, Lorenzo Gerratana, Katherine Clifton, et al.Ebiomedicine|November 4, 2022
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerAndrew A Davis, Lorenzo Gerratana, Katherine Clifton, et al.Pageof 1